SELLAS Life Sciences Group, Inc. Operating Leases, Future Minimum Payments, Due in Two Years
SELLAS Life Sciences Group, Inc. (SLS) had Operating Leases, Future Minimum Payments, Due in Two Years of $224.00 thousand as of 2018-12-31, per its 10-Q filed 2019-11-14.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears · last filed 2019-11-14
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $224.00K.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $76.00K.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $246.00K.
- 2015-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $323.00K.
| Period end | Operating Leases, Future Minimum Payments, Due in Two Years |
|---|---|
| 2018-12-31 | $224.00K 10-Q · filed 2019-11-14 |
| 2017-12-31 | $76.00K 10-K · filed 2018-04-13 |
| 2016-12-31 | $246.00K 10-K · filed 2017-03-15 |
| 2015-12-31 | $323.00K 10-K/A · filed 2016-04-15 |
| 2014-12-31 | $83.00K 8-K · filed 2015-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |